Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

Commentary: Pulling the plug.

Jamieson SW.

J Thorac Cardiovasc Surg. 2019 Aug;158(2):617-618. doi: 10.1016/j.jtcvs.2019.01.106. Epub 2019 Feb 6. No abstract available.

PMID:
30826099
2.

Re: Outcome after surgical treatment of chronic thromboembolic pulmonary hypertension: dealing with different patient subsets. A single-centre experience.

Jamieson SW.

Eur J Cardiothorac Surg. 2016 Nov;50(5):907-908. Epub 2016 May 4. No abstract available.

PMID:
27147627
3.

Efficacy of a Low-Tidal Volume Ventilation Strategy to Prevent Reperfusion Lung Injury after Pulmonary Thromboendarterectomy.

Bates DM, Fernandes TM, Duwe BV, King BO, Banks DA, Test VJ, Fedullo PF, Kim NH, Madani MM, Jamieson SW, Auger WR, Kerr KM.

Ann Am Thorac Soc. 2015 Oct;12(10):1520-7. doi: 10.1513/AnnalsATS.201503-142OC.

PMID:
26241077
4.

Baseline body mass index does not significantly affect outcomes after pulmonary thromboendarterectomy.

Fernandes TM, Auger WR, Fedullo PF, Kim NH, Poch DS, Madani MM, Pretorius VG, Jamieson SW, Kerr KM.

Ann Thorac Surg. 2014 Nov;98(5):1776-81. doi: 10.1016/j.athoracsur.2014.06.045. Epub 2014 Sep 18.

5.

Riociguat for pulmonary hypertension.

Auger WR, Jamieson SW; Pulmonary Thromboendarterectomy Program at University of California, San Diego.

N Engl J Med. 2013 Dec 5;369(23):2266. doi: 10.1056/NEJMc1312903. No abstract available.

PMID:
24304057
6.

Pulmonary artery sarcoma.

Jamieson SW.

Eur J Cardiothorac Surg. 2013 Apr;43(4):793-4. doi: 10.1093/ejcts/ezs362. Epub 2012 Aug 7. No abstract available.

PMID:
22872439
7.

Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients.

Madani MM, Auger WR, Pretorius V, Sakakibara N, Kerr KM, Kim NH, Fedullo PF, Jamieson SW.

Ann Thorac Surg. 2012 Jul;94(1):97-103; discussion 103. doi: 10.1016/j.athoracsur.2012.04.004. Epub 2012 May 23.

PMID:
22626752
8.

Implantation of the eSVS Mesh.

Emery RW, Solien E, Jamieson SW.

Innovations (Phila). 2012 Jan-Feb;7(1):65-7. doi: 10.1097/IMI.0b013e318253fb58.

PMID:
22576039
9.

Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy.

Kerr KM, Auger WR, Marsh JJ, Devendra G, Spragg RG, Kim NH, Channick RN, Jamieson SW, Madani MM, Manecke GR, Roth DM, Shragg GP, Fedullo PF.

Chest. 2012 Jan;141(1):27-35. doi: 10.1378/chest.10-2639. Epub 2011 Aug 11.

10.

Invited commentary.

Thistlethwaite PA, Jamieson SW.

Ann Thorac Surg. 2011 Apr;91(4):1100. doi: 10.1016/j.athoracsur.2011.01.006. No abstract available.

PMID:
21440130
11.

Case 1-2011: The challenges posed by a complicated pulmonary thromboendarterectomy.

Guerrero E, Banks DA, Auger WR, Jamieson SW.

J Cardiothorac Vasc Anesth. 2011 Feb;25(1):183-91. doi: 10.1053/j.jvca.2010.11.002. No abstract available.

PMID:
21272779
12.

Surgical management of endobronchial inflammatory myofibroblastic tumors.

Thistlethwaite PA, Renner J, Duhamel D, Makani S, Lin GY, Jamieson SW, Harrell J.

Ann Thorac Surg. 2011 Feb;91(2):367-72. doi: 10.1016/j.athoracsur.2010.09.017.

PMID:
21256271
13.

Chronic thromboembolic pulmonary hypertension in pediatric patients.

Madani MM, Wittine LM, Auger WR, Fedullo PF, Kerr KM, Kim NH, Test VJ, Kriett JM, Jamieson SW.

J Thorac Cardiovasc Surg. 2011 Mar;141(3):624-30. doi: 10.1016/j.jtcvs.2010.07.010. Epub 2010 Aug 30.

14.

Notch3 signaling promotes the development of pulmonary arterial hypertension.

Li X, Zhang X, Leathers R, Makino A, Huang C, Parsa P, Macias J, Yuan JX, Jamieson SW, Thistlethwaite PA.

Nat Med. 2009 Nov;15(11):1289-97. doi: 10.1038/nm.2021. Epub 2009 Oct 25.

15.

Inhibition of mTOR attenuates store-operated Ca2+ entry in cells from endarterectomized tissues of patients with chronic thromboembolic pulmonary hypertension.

Ogawa A, Firth AL, Yao W, Madani MM, Kerr KM, Auger WR, Jamieson SW, Thistlethwaite PA, Yuan JX.

Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L666-76. doi: 10.1152/ajplung.90548.2008. Epub 2009 Jul 24.

16.

Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension.

Yao W, Firth AL, Sacks RS, Ogawa A, Auger WR, Fedullo PF, Madani MM, Lin GY, Sakakibara N, Thistlethwaite PA, Jamieson SW, Rubin LJ, Yuan JX.

Am J Physiol Lung Cell Mol Physiol. 2009 Jun;296(6):L870-8. doi: 10.1152/ajplung.90413.2008. Epub 2009 Mar 13.

17.

Chronic thromboembolic pulmonary hypertension.

Jamieson SW, Madani M.

Ann Vasc Dis. 2009;2(3):133-5. doi: 10.3400/avd.AVDctpe001009. Epub 2010 Mar 29. No abstract available.

18.

Airway stenoses after lung transplantation: incidence, management, and outcome.

Thistlethwaite PA, Yung G, Kemp A, Osbourne S, Jamieson SW, Channick C, Harrell J.

J Thorac Cardiovasc Surg. 2008 Dec;136(6):1569-75. doi: 10.1016/j.jtcvs.2008.08.021.

19.

Technique and outcomes of pulmonary endarterectomy surgery.

Thistlethwaite PA, Kaneko K, Madani MM, Jamieson SW.

Ann Thorac Cardiovasc Surg. 2008 Oct;14(5):274-82. Review.

PMID:
18989242
20.

Invited commentary.

Jamieson SW, Madani M.

Ann Thorac Surg. 2008 Oct;86(4):1267. doi: 10.1016/j.athoracsur.2008.07.067. No abstract available.

PMID:
18805173
21.

Endothelial expression of bone morphogenetic protein receptor type 1a is required for atrioventricular valve formation.

Kaneko K, Li X, Zhang X, Lamberti JJ, Jamieson SW, Thistlethwaite PA.

Ann Thorac Surg. 2008 Jun;85(6):2090-8. doi: 10.1016/j.athoracsur.2008.02.027.

PMID:
18498827
22.

Outcomes of pulmonary endarterectomy surgery.

Thistlethwaite PA, Madani M, Jamieson SW.

Semin Thorac Cardiovasc Surg. 2006 Fall;18(3):257-64.

PMID:
17185189
23.

Technical advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.

Madani MM, Jamieson SW.

Semin Thorac Cardiovasc Surg. 2006 Fall;18(3):243-9. Review.

PMID:
17185187
24.

Historical perspective: surgery for chronic thromboembolic disease.

Jamieson SW.

Semin Thorac Cardiovasc Surg. 2006 Fall;18(3):218-22.

PMID:
17185183
25.

Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes.

Thistlethwaite PA, Madani MM, Kemp AD, Hartley M, Auger WR, Jamieson SW.

Ann Thorac Surg. 2006 Dec;82(6):2139-45.

PMID:
17126125
26.

Outcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertension.

Thistlethwaite PA, Kemp A, Du L, Madani MM, Jamieson SW.

J Thorac Cardiovasc Surg. 2006 Feb;131(2):307-13. Epub 2006 Jan 18.

27.

Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse.

Kido M, Du L, Sullivan CC, Li X, Deutsch R, Jamieson SW, Thistlethwaite PA.

J Am Coll Cardiol. 2005 Dec 6;46(11):2116-24. Epub 2005 Nov 9.

28.

Chronic thromboembolic pulmonary hypertension and pulmonary thromboendarterectomy.

Manecke GR Jr, Wilson WC, Auger WR, Jamieson SW.

Semin Cardiothorac Vasc Anesth. 2005 Sep;9(3):189-204. Review.

PMID:
16151552
29.

Chronic thromboembolic pulmonary hypertension.

Fedullo PF, Kerr KM, Auger WR, Jamieson SW, Kapelanski DP.

Semin Respir Crit Care Med. 2000;21(6):563-74.

PMID:
16088765
30.

Gene transfer of a TIE2 receptor antagonist prevents pulmonary hypertension in rodents.

Kido M, Du L, Sullivan CC, Deutsch R, Jamieson SW, Thistlethwaite PA.

J Thorac Cardiovasc Surg. 2005 Feb;129(2):268-76.

31.

Hemodynamic observations on a yogic breathing technique claimed to help eliminate and prevent heart attacks: a pilot study.

Shannahoff-Khalsa DS, Sramek BB, Kennel MB, Jamieson SW.

J Altern Complement Med. 2004 Oct;10(5):757-66.

PMID:
15650464
32.

Late recurrence of cardiac sarcoma presenting as giant pulmonary artery aneurysm.

Myruski KS, Manecke GR Jr, Kotzur A, Wahrenbrock EA, Jamieson SW.

J Heart Lung Transplant. 2004 Dec;23(12):1445-6.

PMID:
15607677
33.

Differential myocardial gene delivery by recombinant serotype-specific adeno-associated viral vectors.

Du L, Kido M, Lee DV, Rabinowitz JE, Samulski RJ, Jamieson SW, Weitzman MD, Thistlethwaite PA.

Mol Ther. 2004 Sep;10(3):604-8.

34.

Massive pulmonary hemorrhage after pulmonary thromboendarterectomy.

Manecke GR Jr, Kotzur A, Atkins G, Fedullo PF, Auger WR, Kapelanski DP, Jamieson SW.

Anesth Analg. 2004 Sep;99(3):672-5, table of contents.

PMID:
15333391
35.

Pulmonary thromboendarterectomy.

Thistlethwaite PA, Jamieson SW.

Ann Thorac Surg. 2004 Aug;78(2):746-7. No abstract available.

PMID:
15309813
36.

Pulmonary thromboendarterectomy surgery.

Thistlethwaite PA, Madani M, Jamieson SW.

Cardiol Clin. 2004 Aug;22(3):467-78, vii. Review.

PMID:
15302365
37.

The choice of valve protheses.

Jamieson SW, Madani MM.

J Am Coll Cardiol. 2004 Jul 21;44(2):389-90. No abstract available.

38.

Does lowering pulmonary arterial pressure eliminate severe functional tricuspid regurgitation? Insights from pulmonary thromboendarterectomy.

Sadeghi HM, Kimura BJ, Raisinghani A, Blanchard DG, Mahmud E, Fedullo PF, Jamieson SW, DeMaria AN.

J Am Coll Cardiol. 2004 Jul 7;44(1):126-32.

39.

Interventional and surgical modalities of treatment for pulmonary arterial hypertension.

Klepetko W, Mayer E, Sandoval J, Trulock EP, Vachiery JL, Dartevelle P, Pepke-Zaba J, Jamieson SW, Lang I, Corris P.

J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):73S-80S. Review.

40.

Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension.

Bresser P, Fedullo PF, Auger WR, Channick RN, Robbins IM, Kerr KM, Jamieson SW, Rubin LJ.

Eur Respir J. 2004 Apr;23(4):595-600.

41.

Deep hypothermic circulatory arrest and the femoral-to-radial arterial pressure gradient.

Manecke GR Jr, Parimucha M, Stratmann G, Wilson WC, Roth DM, Auger WR, Kerr KM, Jamieson SW, Kapelanski DP, Mitchell MM.

J Cardiothorac Vasc Anesth. 2004 Apr;18(2):175-9.

PMID:
15073707
42.

A new animal model for pulmonary hypertension based on the overexpression of a single gene, angiopoietin-1.

Chu D, Sullivan CC, Du L, Cho AJ, Kido M, Wolf PL, Weitzman MD, Jamieson SW, Thistlethwaite PA.

Ann Thorac Surg. 2004 Feb;77(2):449-56; discussion 456-7.

PMID:
14759414
43.

Pulmonary endarterectomy: experience and lessons learned in 1,500 cases.

Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, Channick RN, Fedullo PF, Auger WR.

Ann Thorac Surg. 2003 Nov;76(5):1457-62; discussion 1462-4.

PMID:
14602267
44.

Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway.

Sullivan CC, Du L, Chu D, Cho AJ, Kido M, Wolf PL, Jamieson SW, Thistlethwaite PA.

Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12331-6. Epub 2003 Sep 25.

45.

Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors.

Chu D, Sullivan CC, Weitzman MD, Du L, Wolf PL, Jamieson SW, Thistlethwaite PA.

J Thorac Cardiovasc Surg. 2003 Sep;126(3):671-9.

46.

Decreased plasma neurohormones and improved cardiac performance after surgical treatment of chronic pulmonary embolism.

Tulevski II, Bresser P, Hirsch A, Groenink M, Channick RN, Jamieson SW, Mulder BJ.

Ann Thorac Surg. 2003 Jul;76(1):287-90.

PMID:
12842565
47.

Tricuspid valvular disease in the patient with chronic pulmonary thromboembolic disease.

Thistlethwaite PA, Jamieson SW.

Curr Opin Cardiol. 2003 Mar;18(2):111-6. Review.

PMID:
12652215
48.

Signaling molecules in nonfamilial pulmonary hypertension.

Du L, Sullivan CC, Chu D, Cho AJ, Kido M, Wolf PL, Yuan JX, Deutsch R, Jamieson SW, Thistlethwaite PA.

N Engl J Med. 2003 Feb 6;348(6):500-9.

49.

Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy.

Thistlethwaite PA, Mo M, Madani MM, Deutsch R, Blanchard D, Kapelanski DP, Jamieson SW.

J Thorac Cardiovasc Surg. 2002 Dec;124(6):1203-11.

50.

Predicting survival of lung transplantation candidates with idiopathic interstitial pneumonia: does PaO(2) predict survival?

Timmer SJ, Karamzadeh AM, Yung GL, Kriett J, Jamieson SW, Smith CM.

Chest. 2002 Sep;122(3):779-84.

PMID:
12226013

Supplemental Content

Loading ...
Support Center